Shionogi to ready COVID-19 vaccines for 30m people
Japanese drugmaker to lift capacity for coronavirus treatments by end of 2021
Japanese pharmaceutical maker Shionogi hopes to make COVID-19 vaccines for 30 million people a year by the end of 2021. (Source photo by screenshot from Shionogi website and photo courtesy of Shionogi)
TOKYO -- Japanese drugmaker Shionogi plans to increase production capacity for its coronavirus vaccine candidate, aiming to turn out enough vaccines for 30 million people per year by the end of 2021, as competition intensifies to develop COVID-19 treatments, Nikkei has learned.
Shionogi will increase capacity at its plant by more than tripling its previous capacity by adding manufacturing equipment. It plans to carry out all phases of production, including procurement of materials, in Japan.